South San Francisco, CA, June 20, 2018 – Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in...
MUSC Foundation for Research Development welcomes Art Pappas to board
News | 04. 23. 2014
Pappas to share venture capital expertise in pharmaceutical and life sciences industries
CHARLESTON, SC – April 23, 2014 – The Medical University of South Carolina Foundation for Research Development (FRD) has announced that venture capitalist Art Pappas has joined the organization’s Board of Directors, effective immediately.
